Idexx Laboratories (IDXX) Share-based Compensation: 2009-2025
Historic Share-based Compensation for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $14.4 million.
- Idexx Laboratories' Share-based Compensation fell 9.33% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.2 million, marking a year-over-year decrease of 5.06%. This contributed to the annual value of $60.3 million for FY2024, which is 0.93% up from last year.
- According to the latest figures from Q3 2025, Idexx Laboratories' Share-based Compensation is $14.4 million, which was down 2.83% from $14.9 million recorded in Q2 2025.
- In the past 5 years, Idexx Laboratories' Share-based Compensation ranged from a high of $15.9 million in Q3 2024 and a low of $8.9 million during Q1 2021.
- Its 3-year average for Share-based Compensation is $14.9 million, with a median of $14.9 million in 2025.
- Its Share-based Compensation has fluctuated over the past 5 years, first surged by 36.71% in 2022, then decreased by 9.33% in 2025.
- Over the past 5 years, Idexx Laboratories' Share-based Compensation (Quarterly) stood at $9.7 million in 2021, then skyrocketed by 36.71% to $13.3 million in 2022, then rose by 14.64% to $15.2 million in 2023, then decreased by 6.34% to $14.3 million in 2024, then decreased by 9.33% to $14.4 million in 2025.
- Its last three reported values are $14.4 million in Q3 2025, $14.9 million for Q2 2025, and $14.6 million during Q1 2025.